Intrinsic Value of S&P & Nasdaq Contact Us

Processa Pharmaceuticals, Inc. PCSA

NASDAQ Capital Marke

SharesGrow Score
67/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+213.6%

Processa Pharmaceuticals, Inc. (PCSA) current share price is $2.87. The gold spot price is $4,808.10 per troy ounce. Using the formula: PCSA in gold = $2.87 × 31.1035 ÷ $4,808.10 = 0.0186 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of PCSA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding PCSA shares over the measured period.

PCSA in US Dollars
Gold in US Dollars
PCSA in Gold (grams per share)

Real Wealth Growth Rate

PCSA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{PCSA}_{\text{gold}}(t) = \frac{P_{\text{PCSA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{PCSA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{PCSA}_{\text{gold}}^{(T)}}{\text{PCSA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{PCSA}_\text{gold}^{(0)}$ = initial gold-price, $\text{PCSA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CELC
CELC
Celcuity Inc.
$120.85
+0.37%
ELVN
ELVN
Enliven Therapeutics, Inc.
$44.85
+2.33%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.19
+7.40%
ARMP
ARMP
Armata Pharmaceuticals, Inc.
$12.88
+10.18%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
THRD
THRD
Third Harmonic Bio, Inc.
$5.38
-0.09%
MACK
MACK
Merrimack Pharmaceuticals, Inc.
$15.15
+0.10%
FENC
FENC
Fennec Pharmaceuticals Inc.
$6.25
+5.40%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message